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Receptors for syntheti c N-formylated chemotactic pep tides 
o n peripheral blood neutro phils were studied by the bind-
ing offlu orescein-labeled hexapeptide (N-formyl-Nle-Leu-
Phe-Nle-Tyr-Lys) to the cell s in vitro at the range of con-
centrations 0.01 -1 00 nM. M ean flu orescence of neutrophils 
was quantitated by a fl ow cytom etry using FACS III. Com-
parison was made between 27 patients with psoriasis vul-
garis and 14 norm al cont rols. 
Various receptor sta tes rel ated to cell activi ties were in-
duced by different temperatures , by incubation of cells with 
cytochalas in B and by preincubation wi th nonlabeled 
N -formyl-Met-Leu-Phe. This allowed us to distinguish be-
tween the specific binding of flu oresceinated hexapeptide 
to plasma membrane receptor already present (O°C), mod-
ulation of receptors by peptide and cytochalas in B stimu-
la ted degranulation (25°C), and net binding, including in-
ternaliza tion of peptide and receptor recycling system (37°C). 
At peptide concentrations of 1-10 nM, the labeling of 
neutrophils at 25°C and 37°C, but not at O°C, w as found 
to be about 10-35% lower in psoria ti c than in healthy 
su bjects (p < 0.002). The amount of flu orescein-labeled 
A n en hanced res ponsiveness of periph eral blood poly-morphonucl ea r leukocytes (PM NLs) upon stimu-lati on wi th various li gands [1-11], together with infiltra tion of multiple PM NLs in psoriatic epider-mis [1 2], seems to be a characteristic feature of pso-
rias is. Although many possible factors have been suggested to be 
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Abbreviations: 
BSA: bovine serum albumin 
C P: chemotactic pep tides 
ECso: concentra tion giving 50% maximal response 
FACS: Auorescence-activated cell so rter 
FHP: Auoresceinated hexapeptide 
FMLP: N-form yl-methionyl-Ieucyl-phenylalanine 
PMA: phorbol myristate aceta te 
PMNL: polymorphonuclear leukocytes 
peptide bound to the cells at 25°C was m arkedly increased 
by cytochalasin B , but to a much lower extent in psoriati c 
patients than in normal con trols. Although the number of 
plas ma mem brane receptor for chem otacti c peptides in the 
nonstimulated neutrophils was not altered in psoriasis, the 
receptor up-regulation induced by preincubation of the cells 
with 1-10 nM of nonlabeled N-formyl-Met-Leu-Phe at 
37°C was reduced w hen measured by subsequent flu ores-
ceinated hexapeptide uptake at OCC. 
Receptor recycling , as measured by an increase with time 
(0-30 min) in the binding of chem otactic peptide by neu-
trophils in w hich receptors had been down-regulated, was 
found to be with in norm al range in patients w ith psoriasis. 
These data indicate that nonstimulated, circulatin g neu-
trophils have a normal number of chemotactic peptide re-
ceptors on th e cell surface, but are less able to recruit in-
tracellular receptors to the cell surface . This fi ndin g may 
be related to smaller internal pools or less efficient trans-
loca tion of these receptors. J Invest Dermatol 89:523- 528, 
1987 
responsible for chemoatt ra ction of neutrophils to the epidermis 
[13- 17] , those operating in psoriasis have not been identified. 
Number ofPM NLs [1 8.19], adherence to nylon fibers [6,13], 
chemotaxis [1-3,6,7,9], generation of oxygen intermediates [5,6,11 J, 
phagocytos is [1 ,8], C3 [1 0] and FclgG receptor expression [9.10], 
neutrophil-mediated cy totoxicity [4], and neutral proteinase ac-
tivities [17] have all been reported to be in creased in patients w ith 
pso riasis, although some investiga tors have been un able to con-
firm these findin gs [1 9-23]. T he discrepancies are presum ably 
related to patient gro upings as well as insuffi cient numbers of 
patients to reach statistical signifi cance in differences from normal 
controls. Other fun ctio ns, such as degran ul ation , have been re-
ported to be either decreased in guttate psoriasis [24] or normal 
[4], and occu rred in psoriatics at lower doses of CSa and N-
form yl-methion yl-leucy l-phenylalanine (FMLP) than in normal 
subj ects [3]. 
Increased chemotaxis ofPMNLs in psoriasis has been suggested 
to represent a uni versal hyperactive state of these cells, si nce it 
was induced towards different chcmoatrractants such as endo-
toxin- [1 ,21 ] and zymosan- [6] activated serum , Escherichia co li 
filtrate [20,23], FMLP [9], C5a [9] and casein [7,21 ], the mech-
anisms of action of w hi ch are different. Some of th ese chemoa t-
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tractants bind to distin ct m olecul es o n th e cell surface [25-271. 
Factors stimulatin g chem o taxis have also been shown to be prcs-
ent in psori ati c sera [3,19,28,29J. Excessive chemotacti c res pon-
sivcness has been found bo th by in vitro techniques, i. e., b y di-
rected mi grat ion of cells in the Boyden chamber [1 ,3,6,7,91 and 
under agarose 12], and by iIi v ivo skin w indow m eth ods [22,8 1. 
The lead in g front technique, however, did no t show any differ-
ence between patients w ith psoriasis and hea lth y subj ects in th e 
mig ration distance of neutrophil s towards FM LP 11 9], end otox in 
ac ti vated serum [21 J, o r casein 121]. The mechanism under lyin g 
hyper reactivity o f ci rculatin g PMNLs in pso riasis is still a matter 
of speculation, as is the rel ati onship betwecn cxpress ion and dis-
tribution of the recepto rs and the m ove ment of neutro phils fo r 
long periods of tim e in a g radi ent of chemoattrac tant concentra-
tion both in vitro and in vivo. 
To our knowledge, no quantitative studies of recepto rs fo r 
chemoattractants on peripheral blood PMNLs in psorias is are 
avai lable, the chem ota cti c respo nse ha vin g been studied onl y b y 
fun ctio nal assays. 
The purpose of our paper was to co mpare patients with pso-
ri as is w ith norm als, w ith respect to th e ex press ion of receptors 
fo r chem o tacti c peptides (CP) und er different m eta boli c states o f 
the ce ll s, to fo llow kin etic changes of these receptors with special 
res pect to chem oattractant internali zation, and to eva lu ate recep-
to r up-regulation and down-regulati on indu ced by vario us con-
centratio ns of FMLP. 
MATERIALS AND M ETHODS 
Patients T wenty-seven patients w ith pso rias is vul ga ris and 
fo urteen hea lth y, age- and sex-m atched volunteers we re studied. 
N one of the patients had pso riatic arthritis. The patients were no t 
treated systemi ca ll y fo r at least 3 months prior to the experiment. 
Externa l trea tm ent Iud usuall y been discontinued for seve ral da ys 
before testin g. Treatment durin g the ex periment, if an y, consisted 
of em o lient only. Mean age of patients was 36 ± 12 ("17- 68) yea rs 
and skin invo lvem ent 27 ± 16% (5- 65%) of bod y surface. We 
studi ed a tota l o f 18 patients with pl aqu e pso ri as is, 4 with g uttate 
psori as is, 1 w ith pso ri atic erythrod erm a, and 6 w ho were almost 
lesion-free. 
Isolation ofNeutrophils Thirty milliliters o f peripheral blood 
was drawn into a heparinized syringe (6 IU heparin / ml) and mixed 
with an eq ual volume o f 3% Dex tran T-500 (Pharm acia , Uppsa la) 
in saline. The red blood cells were sed imented for 20 min at room 
temperature, and supernatant was layered on th e top of Fico ll-
H ypaque soluti o n (sp g r 1.077). After centrifug in g the g radient 
fo r 40 min at 400 X .!!, lymphocytes from the interface and me-
dium we re removed. N eut[Ophils in the pell et w ere purified f[Om 
contaminatin g red blood cells by a h ypotonic shock. The cells 
were resuspended in 0. 2% N aC I for 20 s and an equal volum e 
of 1. 6% N aC I wa s then added to bring solution to 0.9%. The 
cells we re was hed twi ce in cold phosphate buffered sa line (PBS), 
centrifu ged for 5 min at 120 g, and suspended in a binding buffer. 
The cell suspension consisted of 99% neutro phils of more than 
97% viabi lity by trypan blue exclusion . 
Fluoresceination of Chemotactic Peptide Fluo rescein deri v-
ative of hexa peptide (N-formyl-Nle-Leu-Phe-Nle-T yr-Lys; Sigma, 
St. Loui s, Missouri) was synthesized from Auorcscein isothi o-
cya nate, iso mer I (S ig m a), under th e reacti on conditions used for 
preparin g the analogo us rhodamine derivatives 1301. BrieAy , Auo-
resccin iso thiocya nate (10 mM) was reacted w ith hexapeptide (2 .5 
mM) in 0.25 ml dry dim ethylfo rmamide, containin g 1 % tri-
ethylamine, fo r 18 h at 22°C. The prod uct was purifi ed by thin-
la yer chrom atograp hy in a mixture o f chl o ro form, m ethanol , and 
trieth ylamin e (5:2 :1 by volum e) RI, = 0.31. T his peptide has been 
shown to react w ith the sa me recepto r as FM LP and with a similar 
affinit y [30]. 
The Auorescein derivative was es timated by spectro photometry 
(Beckma n) on the basis of its absorbance at pH 7.4 in PBS in the 
presence of 0.1 % bovine serum albumin (BSA), assuming an 
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extinction coefficient fo r cova lentl y bo und Au o rescc in of 66,800 
M - ' cm - ' at 495 nm. 131], as well as by compari son wi th standard 
Au o rescein conccntratio n abso rbance curve. Fluo resceinated hex-
apeptide (FH P) was also es tim ated o n th e basis o f its tyrosine 
absorbance in 1 M NaOH , assumin g an absorbance at 294 nm of 
2,330 M - 'cm - I 1321. 
Binding Assay T he bindin g of FH P was performed at a cell 
concentration o f about 2 x l O('/ ml in 0.4 ml of PBS with 0.1 % 
BSA , 1 mM CaCI2, and 0.1 mM M gCI2• The neutrophil s were in-
cubated for 5-60 min with FHP at different temperatures (0, 15, 
20, 25, 30, 37°C) , th en was hed w ith cold PBS and suspended 
at a conccntration of l X 10(, cell s/ ml atO°C for FA CS I" anal ys is . 
In so me ex perim ents, PMNLs were prein cubated w ith nonlabeled 
FMLP fo r 10 min at 37°C prio r to labelin g w ith FHP, and in 
others, cells were pretreated w ith cytochalasin B (5 }.Lg/ml)(Sigma). 
Mean cell-bound Auorescence was determined by FA CS III fo r 
10,000 PMNLs usin g an argon laser emittin g 750 mW at 488 nM 
as the excitin g bea m. The result , the mean o f the Auo rescence 
di stributio n, was expressed in arbitra ry units . Cell autoAuores-
cence (backg ro und) o r nonspecifI C binding o f FHP, determined 
b y th e FI-I P uptake in th e presence o f 1000-fo ld excess of non-
labeled FMLP, was subtracted from to tal binding . 
Statistical Comparison Student ' s t test and Wilcoxon's two-
tailed tes t for paired sa mples were used as indiclted in fi gure 
legends. 
n.ES ULTS 
Binding ofFHP by Neutrophils at Different Temperatures 
in Patients With Psoriasis and Normal Controls The uptake 
of FHP into neutrop hils, plotted against peptide concentration , 
showed sa turation at concentratio ns of FHP above 1 nM. The 
ECSli (concentration produ'cin g a res ponse 50% of max im al) fo r 
bindin g at 37°C was about Cl."I nM. T he binding to ncutrophil s 
was specifi c, sin ce it was to tall y blocked by 1000-fold excess of 
nonlabekd FMLP (data no t shown). 
At hi gher concentrations of FHP (above 30 nM), non specifi c 
uptake at 20 and 37°C b y the cell s, whi ch increased linea rly w ith 
FHP concentratio n and co uld no t be co mpeted w ith unl abeled 
peptide, co uld be demonstrated. A similar nonspecific uptake also 
occurred w ith free Auorescein isothi ocya nate alone at a compar-
able concentration (data no t shown). 
The am ount o f FHP in co rporated into neu trophils was depen-
dent on the temperature, in creasing rapidl y at temperatures g reater 
than 20°C, show in g a biphasi c curve w ith a platea u in the 25-30°C 
range and ma xim al binding at 37°C. 
The EC51) fo r binding at O°C was about 3 nM both in patients 
w ith pso riasis and norm al contro ls. In addition, the am ount of 
FI-IP bo und per cell was fo und to be similar in both g roups at 
this temperature at a number of different FHP concentrations (Fig. 
1) . 
T he uptake o f F1-lP b y neutro phil s in patients with psoriasis 
was red uced by co mparison with healthy subjects both at 25 and 
37°C. At higher peptide concent ratio ns (1-1 0 nM) , the difference 
between these two g roups was statisti ca ll y significant. No co r-
relation , positi ve o r nega tive, was o bserved between the decrease 
in FHP binding to ncutrophil s and the extent of pso riatic lesions. 
Binding of FHP Following Up-Regulation of Neutrophil 
CP Receptors 
FMLP-Degra/1//lated Cells: N eutrophil s preincubated at 37°C fo r 
10 min w ith nonlabcled FMLP at concentrati ons from 0. 1 nM to 
1000 nM were found to express on the cell sur f.1ce different amounts 
o f C P receptors, as determined by the subsequent binding of 10 
nM FHP at O°C to washed cells. Exposure of cells to 1-1 0 nM 
no nl abcled FMLP indu ced about 2-fold in crease in the FHP bind-
in g as co mpared with nonprein cubated cells . Incubation with 
hi gher concentrations of nonlabeled FMLP (100-1 000 nM) sig-
nifi cantly reduced the binding ofFHP compared with initial va lli e. 
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Figure 1. The binding (mean ± SE) of Ruoresceinated 
chemotactic peptide to psoriatic (n = 18) and normal 
(n = 14) neutrophils upon incubation with increas ing 
peptide concentrations (0.01-10 nM) at different temper-
atures. Incubation times: O°C, 30 min; 25°C, 30 min ; 37°C, 
10 min. Statistical comparison by Stlldent's t tes t 
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PREINCUBATION WITH NON LABELED FMLP 
Figure 2. The binding (mean ± SE) of 10 nM Ruoresceinated chemo-
tactic peptide at O°C to psoriatic (n = 8) and normal (n = 8) neutrophils 
after preincubation of the cells with nonlabeled FMLP (0. 1-1 ,000 nM) at 
37°C for 10 min. Statistical comparison by Student 's t tes t. 
At the highest concentrations , this FHP binding was only slightly 
higher than background (Fig 2) . 
In similar experiments using neutrophils from patients with 
psoriasis, the FHP binding distribution curve showed maxima 
and minima for FHP binding at similar concentrations of non-
lab eled FMLP in the preincubation. After preincubation with FMLP 
concentrations below 10 nM , however, th e binding of FHP was 
decreased and the m aximal amount of FHP bound, at 30 nM 
FMLP in the preincubation, was found to be significantly lower 
than in normal controls (p < 0.05). 
Cytochalasir/ B-Treated Cells Stim/,dated With CP: Cytochalas in 
B-treated neutrophils from normal controls were demonstrated 
to bind less FHP at a concentration of 0. 1 nM at 25°C than 
nontreated cells. A significant in crease in the amount of peptide 
bound to the cells, compared with non treated controls , was shown 
a t both 1 nM and 10 nM FHP, however (Fig 3). 
In patients with psorias is , the enhancement of FHP binding by 
preincubation of neutrophils w ith cytochalas in B at FHP con-
centrations of 1 nM and 10 nM was much lower than in paired 
analyses using healthy subjects . 
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Figure 3. The binding (mean ± SE) of Ruoresceinated chemotactic pep-
tide (0.1- 10 nM) at 25°C to intact and cytochalasin B-treated neutrophils 
in patients with psorias is (n = 12) and normal controls (n = 12) . Incu-
bation times: intact neutrophils, 30 min ; cytochalasin B-trea ted cells, 10 
min . Sta ti sti ca l significance of the difference in cytochalas in B-induced 
increase in the pept ide binding between psoriati cs and normals by Wil-
coxon's two-tailed tes t for paired sam ples. 
CP Receptor Recycling in Psoriatics and Normal Controls 
The number of receptors for C P on the neutrophil m embrane 
available for binding was marked ly reduced by th e preincubation 
of cells w ith 1000 nM nonlabeled FMLP at 37°C for 10 min. The 
initial binding of FHP by untreated contro l preparations, m ain-
tained in buffer at QOC, w hi ch was abo ut 25 units for psoriatic 
and 22 units for normal neutrophils, was redu ced to about 4 units 
in both psoriatic and normal cell s after pretreatment with FMLP 
at 37°C (Fig 2). When subsequently incubated w ith 1 nM FHP 
at 3rC, psoriatic and normal neutrophils incubated w ith 1 nM 
FHP at 3rC showed increased binding w ith time, w hich reached 
equilibrium after 30 min (Fig 4). The mean amount of FHP pep-
tide incorporated into th e cells at various time points was not 
distinguishable between patients with psoriasis and normals. 
Relationship Between FHP Binding by Neutrophils From 
Psoriatic Patients and Disease Activity The range of FHP 
binding by neutrophils from no rmal and psoriatic patients 
overlapped, but the psoriatics showed slightl y lower binding overall , 
a difference that was signifi can t by Student's t tes t (T able I). 
Disease activity in 16 patients who showed a redu ction of more 
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Figure 4. Increase with time in the binding (mea n ± SE) of 1 nM 
Auoresceinated chemotactic peptide at 37°C to psoriatic (n = 9) and nor-
mal (n = 8) neutrophi ls after preincubation of the cells with 1,000 nM 
non labeled FMLP at 37"C for 10 min. 
th an 2 SD below con trols was no t found to be significa ntl y dif-
ferent from patients w hose FHP binding was w ithin 2 SD o f 
controls (Ta ble II). Six of the patients w ho showed th e reduced 
binding of FHP were almost free of lesions (l ess th an 5% of the 
skin surface affec ted , in volvin g only elbows, knees, and scalp). 
We conclud e th at the depress ion o f FHP binding reported here 
il) psoriatic patients is not related to the severity of disease. 
D ISCUSS ION 
A va riety of hum an polym orph onuclear leukocy te res ponses are 
generated upon exposure of the cells to the sy ntheti c peptide, 
FMLP. The ce lls are stimulated to mig rate in a directed fash ion 
[33] , discharge a po rtion of their lysoso mal content [34), and 
undergo a burst of oxidative metabolism [35). T he cell activation 
is mediated b y the binding of FMLP to structurall y specifi c re-
cepto rs on the PMNL plas m a membrane [36] . Within seconds of 
Table I. Binding of FHP (10 nM) to Pso riatic and Control 
N eutrophils at 37" C for 10 min 
Mean Fl uorescence Student 's 
Mean SO Range t tes t 
Psoriasis (27) 72.4" 11.3 56.7 - 98.7 P < 0.002 
Controls (18) 83.1 7.4 74.2 - 101. 2 
"S ixteen of 27 patients w ith pso riasis showed FHP bind in g reduced mo rc than 2 
SD below th e I11can of nonpso ri a,ic controls. 
Table II. Comparison of C linical Param eters of Psoriasis in 
Patients With Normal and Redu ced FHP Binding to 
N eutrophils (mean ± SD (range)) . 
Group 
Patients with FHP uptake 
within norm al range 
[II] 
Patients with FHP uptake 
2 SO below mean of 
controls r 16[ 
Extent of 
lesions (%) 
36 ± 28 
(5-1 00) 
29 ± 21 
(5- 90) 
"Criteria as in refs 17. 24. Jnd 28. 
Duration 
of disease 
2.9 ± 2.3 mo 
(3 wk-7 mol 
3.1 ± 2.5 mo 
(2 wk- 8 mol 
Acti vity of 
disease il 
1.00 
0.94 
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contact, the hig h-affi nity co mplex between liga nd and specific 
recepto r is internalized , and the number of surface receptors avail-
able for bindin g decreases . This is termed down-regul ation [37]. 
At the sa me tim e, upon stimulation , PMNLs degranul ate. An 
additi ona l intracellular poo l of receptors is ex pressed on the cell 
surface by fusion of specifi c g ranules w ith th e plasma membrane 
[38], causin g an in crease, or up-regul ation , in surface receptors. 
At low concentration s ofFMLP the second process predominates , 
ca usin g net up-regulat ion of recep to rs, w hereas at hig h co ncen-
tra tions th e first beco m es m o re impo rtant , leadin g to net down-
regul ation . The FMLP-recep to r co mplex di ssocia tes in side the 
cell and peptide accumulates, being stored in the cyto pl as m and 
undergoin g degradation, w hile so me receptors freed from the 
co mplex arc recycled to th e cell membrane [37,39). 
In o rder to fo llow dynami c changes of rece pto rs after binding 
ofCP to neut rophils , we selected several experimental conditions, 
which charac te ri ze different stages of recepto r m etabolism and 
turnover (T able III ). Thus, at O°C we could eliminate receptor 
intern ali zati on and ex pressio n co mpletely, and study surface oind-
in g largely isolated from other effects. In the presence of cyto-
chal as in B, inte rnaliza tion was large ly eliminated, and b y prein-
cubation w ith FMLP, net change in surface receptors and receptor 
recovery could be es tim ated . The possibl e contribution of FHP 
binding to cell s o ther than neutrophils was minimi zed by selectin g 
only th ose cells w hose forward scat ter lay w ithin a suitable w in-
dow during fl ow cyto m etri c analysis . 
The binding ofFHP at O°C represented the m embrane binding 
by metabolically inacti ve cells unable to perfo rm receptor inter-
nalization and up-regul ation fro m th e intern al pool (40). The 
labelin g of PMNLs with in creasin g concentrations of FHP in 
patients with pso riasis was not different from that of norm al 
contro ls, w hich suggested the no rmal nun1.ber o f the plas m a 
membran e C P recepto rs in res tin g cell s in pso riasis. This speaks 
aga inst the presence of circulatin g facto rs causin g in vivo de-
granulation of the PMNLs, wh ich has been suggested previously 
[9,24,29]. Degranu lati ve factors such as C5a , A23187, and PMA 
have been found to change the response of PMN Ls to o th er factors 
app lied subseq uentl y, and the express ion o f C P receptors on the 
cel ls [46). 
The uptake of FHP by psoriatic neut rophils was significantl y 
decreased at bo th 25°C and 37°C co mpared with hea lth y subj ects. 
This indi cated that alterati on of the pheno mena present alread y 
at the temperature of 25°C, such as degran ul atio n, rather th an the 
changes in the receptor internaliza ti on of recycling, w hi ch require 
a temperature of 37°C and are m argin al at 25°C, a re responsible 
fo r the redu ction in the FHP uptake. This is in accordance w ith 
studies of degranulation of PMNLs in vitro, stimul ated either 
w ith FMLP o r C3b-opsonized zy m osa n, w hi ch were reported to 
have a reduced effect in pati ents w ith pso rias is [24). The reduced 
binding was not related to disease extent and was found in patients 
w ho were almost les ion-free. 
In this pape r, up-regulation of C P receptor by degranulation 
was induced in two ways : b y prein cubation of PMNL w ith ad-
eq uate concentrations of unl abeled FMLP at 37°C for 10 min , and 
by in cubation of cells w ith FHP in the presence of cytochalasin 
B at 25°C for 10 min. 
In th e first type of ex perim ent, recepto rs ex pressed on th e cell 
surfa ce after preincubation w ith FMLP were immo bil ized on the 
plas ma membran e at O°C, w hi ch allowed co mparison of dose 
dependent up-regulation and , at hig her concentrations of FMLP, 
down-regulatio n of CP receptors. The lower number of up-reg-
ul ated receptors in patients w ith psoriasis favored defective up-
regulati on of C P receptors as th e m echanism responsible for re-
duced FHP uptake by the cells. 
This conclusion was furth er supported in the second type of 
experiment, by the binding of FHP to cytochalas in B-trea ted 
cell s in patients w ith psoriasis. Cytochal as in B is known to induce 
a hypersecretory state of neut rop hils and to m aximize the dis-
charge of granu les in th e presence of stimuli [47] . Cyto chalas in 
B also prevents internaliza tion of FMLP-specific receptor co m-
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Table III. Behavior of Receptors for Chemotactic Peptides on N eutrophil s Under Selected Experimental Conditions 
Incubation Conditions Receptor State 
O°C (5- 30 min )" 
25°C (30 min) 
FHP bound exclusivel y on the cell membrane 140] 
Binding to cell membrane receptor 1411, 
Receptor exposed from internal pools through degranulation 142], 
Marginal receptor interna liza tion" 
37"C (10 min) Binding to cell membrane receptor 136,4 1]' 
Receptor ex posed from internal poo ls through degranulation 142], 
Internaliza tion of liga nd-receptor complex 136,43], 
Recepto r recycl ing" 144], 
Receptor up-regulated (1-10 nM) 137 ], 
25°C ( \0 min) + cy tocl13bsin B 
Receptor down-regulated (100-1, 000 nM FMLP) 137] 
Binding to cell m embrane receptor 1451 
Receptor exposed from internal pools through degranulation" 
Receptor internali za tion inhibited 145] 
Preincubation w ith FMLP at 37"C, 10 min 
+ incubation w ith FHP, O°C, 5-30 min 
Recepto r up-regulated (1-1 0 nM) \371, 
Receptor down-regulated (100-1,000 nM) [37] 
olTilllc IlCccss3ry to reach conAu cll cc. 
"Glinsk i W. Mal1sbridge IN . Unpublished results. 
p lex [451 by blockin g the association of actin w ith cytoskeleton 
[481· The number of receptors, which were expressed throug h 
deg ranulation from intracellul ar pool by cytochalasin B-treated 
pso riati c PMNLs, was markedly dimin ished in comparison with 
normal PMNLs. 
/n COlltras t to defecti ve up-reg ulation of CP receptors in pso-
rias is, recepto r recycl in g in these cells was not affected. PMNLs 
w ith receptors down-regulated by preincubation with 1 J.LM non-
labeled FMLP, recovered their receptors with the same rate as 
no rmal cell s. This indi ca tes that the receptor recovery to the 
plasma membrane after di ssociation of ligand-CP receptor co m-
plex, as well as subsequent internaliza tion of these recepto rs, was 
no rmal in psoriasis. 
Possible exp lanat ions of impaired up-regulation of C P recep-
to rs in psoriasis are either a smaller internal pool of receptors o r 
less efficient translocation of these receptors to the cell m embrane 
(including membran e fu sion). The precise m echanism of defe ctive 
expression of new C P receptors by stimulated, metaboli ca lly ac-
tive, psoriati c neutrophils has yet to be elucidated , however. 
It is difficult to interpret th ese data with respect to relationship 
be tween neutrophil chemotaxis and C P receptor turnover in pso-
rias is. N eutrophil chem otaxis is blocked by the binding o f wheat 
germ agglu tinin to CP receptors, which prevents receptor re-
cycling [44J. Presum abl y, constant, repeated dow n-regulation of 
the receptors and their recycling all ow PMNLs to sta y in a che-
motactic g radient for man y hours [49]. Chemotaxis has been 
fo und to be defective in patients with a specific granule deficiency, 
w h o had decreased FMLP binding and fai led to express more 
receptors after exposure to PMA [50.J. Thus, decreased chemo-
tax is is related to lower receptor recycling and deficit of specifi c 
granules. 
The question of how th e increased chemotactic response of 
P MNLs in pso riasis, reported by mallY authors [1-3,6,7,9], is 
related to defectiv e up-regulation of C P receptors without alter-
atio n of recyclin g, remains unanswered and needs further in ves-
tiga ti on. One of the possible interpretation s is th at C P receptors 
are mobilized [rom an intracellular pool in psorias is in a more 
eeonomical mann er, w hich enables the cells to migra te longer in 
the chemotactic gradient. Alternati vely, the lower occupancy of 
receptors in psorias is, w hich is able to induce chemotaxis, m ay 
gen erate respirato ry burst response quantitati vely different from 
normals. The res pirato ry burst is attributed to high occupation 
of receptors [51] and the normal chemotactic response is known 
to b e inhibited by excessive doses of chemoattractant [52]. The 
triggering of a respiratory burst in psorias is at a lower receptor 
occupan cy does no t necessa ril y entail suppression of neutrophil 
chemotaxis at a lower peptide concentration than normal , however. 
Finall y, it is not known w hat relation the described dysfun ction 
of n eutrophils has to the intrinsic genetic defect in psoriasis . 
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